Platelet function and fibrinolytic activity in borderline and mild hypertension. the influence of age, exercise, smoking and antihypertensive therapy
Fornitz, G.G.
Danish Medical Bulletin 49(3): 210-226
2002
ISSN/ISBN: 0907-8916 PMID: 12238282 Document Number: 542604
Document emailed within 1 workday
Related Documents
Winther, K.; Gleerup, G.; Hedner, T. 1992: Enhanced risk of thromboembolic disease in hypertension from platelet hyperfunction and decreased fibrinolytic activity: has antihypertensive therapy any influence? Journal of Cardiovascular Pharmacology 19(Suppl 3): S21-S24Wocial, B.; Januszewicz, W.; Bar-Andziak, E.; Grzesiuk, W.; Kuczyńska, K.; Berent, H.; Ignatowska-Switalska, H.; Kapiński, M.; Młyński, J. 1990: Platelet activity, prostacycline metabolite, plasma lipids and sympathoadrenal activity in patients with borderline hypertension and a positive family history of hypertension Cor et Vasa 32(4): 265-273
Sharma, S.C.; Saini, J.S. 1981: Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in hypertension Journal of the Association of Physicians of India 29(5): 359-363
Hilleman, D.E.; Mohiuddin, S.M.; Lucas, B.D.; Stading, J.A.; Stoysich, A.M.; Ryschon, K. 1994: Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension Clinical Therapeutics 16(1): 88
Arabidze, G.G.; Dmitriev, V.V.; Rogoza, A.N. 1994: A new approach to the evaluation of the effectiveness of antihypertensive therapy in patients with mild and moderate arterial hypertension based on the example of isoptin retard Klinicheskaia Meditsina 72(5): 27-30
Sharma, V.K.; Narkiewicz, K.; Borys, B.; Furmański, J.; Majkowicz, M.; Krupa-Wojciechowska, B. 1998: The influence of 5-week relaxation therapy on arterial blood pressure in patients with borderline hypertension Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 4(24): 319-322
Uzcátegui Contreras, D.; Granadillo Vera, D.; Salinas, P.J.; Alvarez, N. 1999: A strategic family medicine model for controlling borderline and mild arterial hypertension Atencion Primaria 24(7): 417-420
Bialy, G.B.; Ruddy, M.C.; Malka, E.S.; Silvay, L.A.; Kamalakannan, N. 1988: Comparison of office, home and 24-hour ambulatory blood pressures in borderline and mild hypertension Angiology 39(8): 752-760
Rysánek, K.; Prikryl, P.; Kvetnanský, R.; Kunovská, V.; Rechtoríková, O.; Dohnalová, I. 1982: Symphathetic activity in labile essential hypertension in young men. Part II. Influence of exercise on plasma catecholamines Activitas Nervosa Superior 24(1): 30-31
Savioli, R.M.; Lima, E.V.; Estrella, L.A.; Puppi, E.J.; Praxedes, J.N.; Nassif, M.; Stoeber, G.H.; Del Nero Júnior, E. 1984: Antihypertensive effect of captopril in patients with mild or moderate systemic arterial hypertension Arquivos Brasileiros de Cardiologia 42(1): 67-71
Celentano, A.; Galderisi, M.; Tammaro, P.; Mureddu, G.F.; Garofalo, M.; de Simone, G.; de Divitiis, O. 1991: Slow-release isradipine in mild to moderate hypertension: hemodynamic and antihypertensive effects International Journal of Clinical Pharmacology Therapy and Toxicology 29(12): 494-498
Peters, F.T.; Booij, A.C.; van der Graaf, F.; Vader, H.L.; Gerlag, P.G. 1987: Influence of low-dose acetylsalicylic acid on platelet function in patients on renal replacement therapy Netherlands Journal of Medicine 31(5-6): 210-217
Pessano, B.; La Brocca, A.; Pozzallo, G.; Fontan, V.; Davì, S.; Lussiatti, L. 1989: Antihypertensive efficacy and effects on quality of life of captopril in mild-to-moderate arterial hypertension Minerva Medica 80(6): 595-598
Kuramoto, K.; Matsushita, S.; Kuwajima, I.; Mifune, J.; Sakai, M.; Iwasaki, T.; Murakami, M. 1979: Evaluation of antihypertensive agents for the treatment of mild and intermediate hypertension--results of 4 years of prospective studies Nihon Rinsho. Japanese Journal of Clinical Medicine 37(10): 3465-3471
Tomov, I. 1985: Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension Vutreshni Bolesti 24(6): 39-47
Guicheney, P.; Baudouin-Legros, M.; Meyer, P. 1987: In vivo platelet activation in mild arterial hypertension Archives des Maladies du Coeur et des Vaisseaux 80(6): 808-811
Kawanishi, D.T.; Reid, C.L.; Gonzales, A.; O'Rourke, R.A.; Rahimtoola, S.H. 1989: Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina Circulation 80(6 Suppl): Iv162-Iv170
Rankinen, T.; Väisänen, S.; Penttilä, I.; Rauramaa, R. 1995: Acute dynamic exercise increases fibrinolytic activity Thrombosis and Haemostasis 73(2): 281-286
Hofmann, B.; Meisgeier, U.; Kertscher, P.; Ostermann, G. 1988: Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat Biomedica Biochimica Acta 47(10-11): S161-S164
Escolar, G.; Cases, A.; Viñas, M.; Pino, M.; Calls, J.; Cirera, I.; Ordinas, A. 1999: Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation Haematologica 84(7): 614-619